Hims & Hers Health Inc’s filing revealed that its Chief Operating Officer Baird Melissa unloaded Company’s shares for reported $0.17 million on Apr 08 ’24. In the deal valued at $14.74 per share,11,751 shares were sold. As a result of this transaction, Baird Melissa now holds 538,932 shares worth roughly $8.02 million.
Then, Baird Melissa sold 11,751 shares, generating $171,372 in total proceeds. Upon selling the shares at $14.58, the Chief Operating Officer now owns 538,932 shares.
Before that, Dudum Andrew sold 188,888 shares. Hims & Hers Health Inc shares valued at $2,828,075 were divested by the Chief Executive Officer at a price of $14.97 per share. As a result of the transaction, Dudum Andrew now holds 0 shares, worth roughly $0.0.
Imperial Capital upgraded its Hims & Hers Health Inc [HIMS] rating to an Outperform from a an In-line in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in late February with a ‘”a Market perform”‘ rating. Imperial Capital began covering HIMS with “an In-line” recommendation on December 07, 2023. TD Cowen started covering the stock on July 28, 2023. It rated HIMS as “an Outperform”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 2.55% to $14.88. Over the last five days, the stock has lost -4.98%. Hims & Hers Health Inc shares have risen nearly 67.19% since the year began. Nevertheless, the stocks have risen 52.30% over the past one year. While a 52-week high of $17.16 was reached on 03/25/24, a 52-week low of $5.65 was recorded on 01/05/24. SMA at 50 days reached $12.60, while 200 days put it at $8.86. A total of 3.35 million shares were traded, compared to the trading of 7.35 million shares in the previous session.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 14.53, which if violated will result in even more drops to 14.19. On the upside, there is a resistance level at 15.14. A further resistance level may holdings at 15.39. The Relative Strength Index (RSI) on the 14-day chart is 53.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.93, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.03%. Stochastics %K at 17.64% indicates the stock is a buying.
How much short interest is there in Hims & Hers Health Inc?
A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on Mar 15, 2024, dropping by -0.71 million shares to a total of 12.76 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 13.47 million shares. There was a decline of -5.56%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 7.99% of the overall stock float, the days-to-cover ratio (short ratio) fell to 1.71.
The most recent change occurred on April 11, 2023 when Robert W. Baird began covering the stock and recommended ‘”a Neutral”‘ rating along with a $10 price target.
